AnHeart Announces Publication of Pooled Analysis of two Phase 1 Studies of Taletrectinib in ROS1+ NSCLC

NEXT STORY
OREGON HEALTH & SCIENCE UNIVERSITY JOINS MULTICENTER COVID-19 BVA-100® STUDY
PREV STORY
Vaccinex to Present Additional SIGNAL Data at Huntington Study Group 2020 Medical Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global Pharmaceuticals Market Report 2021: Market is Expected to Grow from $1228.45 Billion in 2020 to $1250.24 Billion in 2021 – Long-term Forecast to 2025 & 2030

author_avatar
NASDAQ Market News

Intellia and Regeneron Announce Landmark Clinical Data Showing Deep Reduction in Disease-Causing Protein After Single Infusion of NTLA-2001, an Investigational CRISPR Therapy for Transthyretin (ATTR) Amyloidosis

author_avatar
NASDAQ Market News

CorMedix Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update

author_avatar
NASDAQ Market News